ARCHIVES

ASCO President Swain: “Shattering Impact on Cancer Enterprise”

This article is from The Cancer Letter archive.

Vol. 39 No. 07 | February 15, 2013

Download PDF Visit The Full Archive

Related Articles

NCI program announcement available, contract awards listed.

November 14, 2003

Upton Struggling To wrap Up Reorganization Of DCCR Before Next Week’s Meeting Of NCAB

September 28, 1979

Zevalin Regimen Better Than Rituximab Alone For NHL

June 29, 2001

ODAC Member Critical Of Amgen For Price Incentives.

March 21, 2008

Division Directors Won’t Control Grants Budget, Upton Insists

February 24, 1978

Oxaliplatin Regimen May Beat Standard For Advanced Colorectal Cancer, NCI Says

May 3, 2002